Live News Categoriesequity

Hanmi Science Co., Ltd. (008930.KS) News

Follow Hanmi Science Co., Ltd. (008930.KS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 008930.KS Asset equity Sector Markets 90 days 1 Last 57,700 Updated Sep 29, 2026, 09:47 AM UTC Open live news feed

M Hanmi Pharma unit says Genentech ends belvarafenib license, returns rights Hanmi Pharmaceutical received Genentech notice ending its belvarafenib (HM95573) licensing deal on Sept. 29, 2026, with termination effective 90 days from notice and rights reverting to Hanmi Pharmaceutical. Hanmi will k EQUITY | Sep 29, 2026, 09:47 AM UTC